DOW JONES22,327.48+690.70 3.19%
S&P 5002,626.65+85.18 3.35%
NASDAQ7,774.15+271.77 3.62%

Ligand Pharmaceuticals Q4 EPS $0.71 Beats $0.61 Estimate, Sales $27M Beat $25.16M Estimate

Ligand Pharmaceuticals (NASDAQ:LGND) reported quarterly earnings of $0.71 per share which beat the analyst consensus estimate of $0.61 by 16.39 percent. This is a 58.24 percent decrease over earnings of $1.7 per share

Benzinga · 02/06/2020 21:01

Ligand Pharmaceuticals (NASDAQ:LGND) reported quarterly earnings of $0.71 per share which beat the analyst consensus estimate of $0.61 by 16.39 percent. This is a 58.24 percent decrease over earnings of $1.7 per share from the same period last year. The company reported quarterly sales of $27 million which beat the analyst consensus estimate of $25.16 million by 7.31 percent. This is a 54.69 percent decrease over sales of $59.59 million the same period last year.